有趣的是，Infigratinib最初于2021年获批用于胆管癌，后因适应症开发策略调整而主动撤回。如今，其有望在ACH赛道迎来“第二春”。基于其疗效和口服便利性，BridgeBio在今年的JPM大会上预测，该药Infigratinib将占据ACH治疗市场50%以上的份额。
Lex: FT's flagship investment column
。业内人士推荐PDF资料作为进阶阅读
cd secure-env-demo
a reason we chose a language that compiles to native machine code, and a reason
Proactively plan for a pause in scaling. We will manage our plans and finances to support a pause in model training if one proves necessary, or an extended delay between training and deployment of more advanced models if that proves necessary. During such a pause, we would work to implement security or other measures required to support safe training and deployment, while also ensuring our partners have continued access to their present tier of models (which will have previously passed safety evaluations).